Document is current
Any future updates will be listed below
-
Authors
Assi, Ahmad
Jalbout, Johnny
Youssef, Bryan
Diab, Ernest
Kourie, Hampig-Raphaël
-
Funding
Funding for this research was provided by:
Pfizer (74270469)
- License Information
-
More Information
Article History
Received: 29 April 2025
Accepted: 24 September 2025
First Online: 22 October 2025
Declarations
:
: Ethical approval for the study was obtained after deliberation by the Ethics Committee of Hotel-Dieu de France (CEHDF File 2113). Informed consent was obtained from all participants prior to their inclusion in the study, and all procedures were conducted in accordance with the ethical standards of the Declaration of Helsinki.
: Not applicable. This manuscript does not contain any individual person’s data in any form (including images, videos, or case details).
: H.K. has received funding from Pfizer and Merck for the development of the BlaCancer mobile application. This funding was provided to support the design and development of the application. The funder had no role in data collection, analysis, interpretation, or manuscript preparation.
